MX390509B - Formulación de nicotina. - Google Patents

Formulación de nicotina.

Info

Publication number
MX390509B
MX390509B MX2020012810A MX2020012810A MX390509B MX 390509 B MX390509 B MX 390509B MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 390509 B MX390509 B MX 390509B
Authority
MX
Mexico
Prior art keywords
nicotine formulation
nicotine
formulation
relates
via inhalation
Prior art date
Application number
MX2020012810A
Other languages
English (en)
Spanish (es)
Other versions
MX2020012810A (es
Inventor
Brian O''rourke
Christopher Nolan
Joseph Kavanagh
Kieran Raleigh
Original Assignee
Yatzz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yatzz Ltd filed Critical Yatzz Ltd
Publication of MX2020012810A publication Critical patent/MX2020012810A/es
Publication of MX390509B publication Critical patent/MX390509B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0085Inhalators using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
MX2020012810A 2018-06-01 2019-05-31 Formulación de nicotina. MX390509B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18175640.4A EP3574902A1 (en) 2018-06-01 2018-06-01 Nicotine formulation and mode of delivery
PCT/EP2019/064212 WO2019229249A1 (en) 2018-06-01 2019-05-31 Nicotine formulation

Publications (2)

Publication Number Publication Date
MX2020012810A MX2020012810A (es) 2022-03-08
MX390509B true MX390509B (es) 2025-03-11

Family

ID=62528283

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012810A MX390509B (es) 2018-06-01 2019-05-31 Formulación de nicotina.

Country Status (13)

Country Link
US (2) US11833145B2 (https=)
EP (3) EP3574902A1 (https=)
JP (1) JP7224375B2 (https=)
CN (1) CN112218637A (https=)
AU (2) AU2019276357B2 (https=)
BR (1) BR112020024088B1 (https=)
ES (1) ES2883799T3 (https=)
MA (2) MA50205B1 (https=)
MX (1) MX390509B (https=)
PL (1) PL3684362T3 (https=)
SG (1) SG11202011761XA (https=)
WO (1) WO2019229249A1 (https=)
ZA (1) ZA202007717B (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817868D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
BR112021010222A2 (pt) * 2018-12-31 2021-08-24 Philip Morris Products S.A. Formulação de nicotina líquida compreendendo solventes imiscíveis em água
PL3905908T3 (pl) 2019-06-20 2025-03-24 Shaheen Innovations Holding Limited Ultradźwiękowe urządzenie rozpylające do użytku osobistego
FR3102041B1 (fr) * 2019-10-22 2025-02-14 Aroma Sens Edulcorant pour liquides de cigarette électronique
US12233207B2 (en) 2019-12-15 2025-02-25 Shaheen Innovations Holding Limited Mist inhaler devices
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
ES3014051T3 (en) 2019-12-15 2025-04-16 Shaheen Innovations Holding Ltd Mist inhaler devices
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
JP7583061B2 (ja) 2019-12-15 2024-11-13 シャヒーン イノベーションズ ホールディング リミテッド 超音波ミスト吸入器
US12213516B2 (en) 2019-12-15 2025-02-04 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US12121056B2 (en) 2019-12-15 2024-10-22 Shaheen Innovations Holding Limited Hookah device
PL4292632T3 (pl) 2019-12-15 2025-11-24 Shaheen Innovations Holding Limited Ultradźwiękowy inhalator mgiełki
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
US11911559B2 (en) 2019-12-15 2024-02-27 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11944120B2 (en) 2019-12-15 2024-04-02 Shaheen Innovations Holding Limited Ultrasonic mist inhaler with capillary retainer
US12201144B2 (en) 2019-12-15 2025-01-21 Shaheen Innovations Holding Limited Hookah device
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US12538944B2 (en) 2019-12-15 2026-02-03 Shaheen Innovations Holding Limited Nicotine delivery device with identification arrangement
BR112022011449A2 (pt) * 2019-12-18 2022-08-30 Philip Morris Products Sa Formulação para uso em um sistema gerador de aerossol
JP7609561B2 (ja) * 2020-02-05 2025-01-07 日本たばこ産業株式会社 液体加熱式の加熱型香味吸引器用の液体組成物
IL296737A (en) 2020-03-27 2022-11-01 Mcneil Ab A cartridge with nicotine
MA57567B1 (fr) * 2020-04-06 2022-09-30 Shaheen Innovations Holding Ltd Dispositifs d'inhalateur de brouillard
CN111802686A (zh) * 2020-07-27 2020-10-23 湖北中烟工业有限责任公司 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟
CN111855866A (zh) * 2020-08-25 2020-10-30 甘肃烟草工业有限责任公司 一种快速测定烟用添加剂中甲醛的方法
IL303786B2 (en) * 2020-12-15 2024-07-01 Shaheen Innovations Holding Ltd Mist inhaler devices
CN114947174A (zh) * 2021-02-25 2022-08-30 深圳市合元科技有限公司 气溶胶形成基质以及气溶胶生成系统
CN113197330A (zh) * 2021-04-28 2021-08-03 深圳市博睿生物科技有限公司 一种电子烟新型甜味剂及制备方法及应用
IL283002A (en) * 2021-05-06 2022-12-01 Nicogen Ltd Nicotine formulations and aerosols
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves
CN116326810B (zh) * 2021-12-22 2026-03-17 深圳市富淼生物科技有限公司 水基雾化剂、指定用途水基雾化物、雾化弹以及雾化装置
CN114886145A (zh) * 2022-06-10 2022-08-12 广州市维城生物科技有限公司 一种水基烟碱电子烟雾化液及其制备方法
KR20240012197A (ko) * 2022-07-20 2024-01-29 주식회사 케이티앤지 표면파 아토마이저에 사용하기 위한 액상형 흡입제형, 이를 포함하는 카트리지 및 에어로졸 생성장치
KR102872477B1 (ko) * 2022-08-10 2025-10-20 주식회사 케이티앤지 니코틴 흡입성 조성물 및 이를 포함하는 에어로졸 발생 장치 및 시스템
CN116019250B (zh) * 2022-12-22 2025-02-14 东莞市吉纯生物技术有限公司 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法
WO2024138377A1 (zh) * 2022-12-27 2024-07-04 思摩尔国际控股有限公司 一种雾化液、雾化器及电子雾化装置
WO2024161313A1 (en) * 2023-01-31 2024-08-08 Rai Strategic Holdings, Inc. Stabilized aerosol precursor formulations
CN118787123A (zh) * 2023-04-14 2024-10-18 思摩尔国际控股有限公司 一种水基电子烟雾化制剂及其制备方法和应用
PL446676A1 (pl) * 2023-11-08 2025-05-12 Dmitrii Shesternenko Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję
FR3159394A1 (fr) * 2024-02-19 2025-08-22 Swm Holdco Luxembourg Feuille de papier comprenant un extrait de plante et de la nicotine stabilisée
CN117898466B (zh) * 2024-02-29 2024-09-24 深圳市艾斯摩迪斯科技有限公司 一种复合尼古丁盐的制备方法及其应用
CN120923467A (zh) * 2025-07-31 2025-11-11 深圳曼华生物科技有限公司 尼古丁盐的制备方法、检测方法、制备的尼古丁盐及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
WO2014182736A1 (en) * 2013-05-06 2014-11-13 Ploom, Inc. Nicotine salt formulations for aerosol devices and methods thereof
CN110367592B (zh) * 2013-07-19 2022-12-02 奥驰亚客户服务有限责任公司 电子吸烟器具的液体气溶胶制剂
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery

Also Published As

Publication number Publication date
MX2020012810A (es) 2022-03-08
BR112020024088A2 (pt) 2021-02-17
US20210196700A1 (en) 2021-07-01
AU2019276357A1 (en) 2020-11-26
JP2021526147A (ja) 2021-09-30
US11833145B2 (en) 2023-12-05
EP3909581A1 (en) 2021-11-17
ZA202007717B (en) 2026-03-25
CN112218637A (zh) 2021-01-12
EP3684362B1 (en) 2021-06-23
MA50205A (fr) 2020-07-29
CA3099940A1 (en) 2019-12-05
MA50205B1 (fr) 2021-09-30
AU2023202855B2 (en) 2024-08-22
PL3684362T3 (pl) 2021-12-20
BR112020024088B1 (pt) 2022-10-11
EP3684362A1 (en) 2020-07-29
SG11202011761XA (en) 2020-12-30
US20240050424A1 (en) 2024-02-15
MA54714A (fr) 2021-11-17
AU2023202855A1 (en) 2023-05-25
ES2883799T3 (es) 2021-12-09
JP7224375B2 (ja) 2023-02-17
WO2019229249A1 (en) 2019-12-05
AU2019276357B2 (en) 2023-04-20
NZ769793A (en) 2024-05-31
EP3574902A1 (en) 2019-12-04

Similar Documents

Publication Publication Date Title
MX390509B (es) Formulación de nicotina.
ZA202000494B (en) Nicotine salts and methods of making and using same
PH12019502058A1 (en) Farnesoid x receptor agonists and uses thereof
EP3289895A4 (en) COMBUSTION FREE TASTE INHALER, SOURCE UNIT FOR TASTE INHALATION COMPONENT AND DISPERSION UNIT
MX2016015179A (es) Una formulación líquida que comprende nicotina para administracion en aerosol.
CY1121373T1 (el) Μεθοδος και φαρμακοτεχνικη μορφη για εισπνοη
EP4552512A3 (en) Nicotine liquid formulations for aerosol devices and methods thereof
PH12018502109A1 (en) Medicine obtained by combining fxr agonist and arb
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
MX384606B (es) Formulaciones de sal de nicotina para dispositivos de aerosol y métodos de los mismos.
CY1122716T1 (el) Ρινικη συσταση κονεως για την αγωγη της υπογλυκαιμιας
PH12018500586B1 (en) Farnesoid x receptor agonists and uses thereof
BR112015027096A2 (pt) dispositivos de respiração e sistemas e métodos relacionados" reivindicação de prioridade
PH12018500544A1 (en) Inhalable nicotine formulations, and methods of making and using thereof
UA45271S (uk) Пристрій для доставляння нікотинвмісного порошку в організм курця
PH12021550605A1 (en) Farnesoid x receptor agonists and uses thereof
SA522431304B1 (ar) عمليات تحضير اللاسميديتان وملح الأسيتات منه
AR095547A1 (es) Nebulizador para bebes y pacientes con compromiso respiratorio
EA201892327A1 (ru) Ингаляционные и назальные бензодиазепины
MX389399B (es) Una formulación de rapamicina inhalable para el tratamiento de hipertensión pulmonar.
EP3661576A4 (en) MEDICAL NEBULIZER FOR FAST DRUG DELIVERY
CL2017001859A1 (es) Inhalador de polvo seco que comprende propionato de fluticasona y xinafosfato de salmeterol
MX2019010263A (es) Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas.
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
EP3962661C0 (en) NASAL DRUG DELIVERY DEVICES